explore -WSS

explore

author：comprehensive 2025-09-27 20:59:10 - browse：627

Venture capital firm RA Capital is starting a new incubator, setting the stage for the firm to create new startups over the next several years that hone in on synthetic biology, a long-gestating field that insiders say is getting renewed interest.

The Boston-based VC’s incubator is called RASyn, and will be led by Robert Nicol, according to people familiar with the firm’s plans. Nicol spent more than 20 years at the Broad Institute, where he co-founded the MIT-Broad Foundry for Synthetic Biology, as well as HiFiBio Therapeutics and Design Pharmaceuticals.

RA Capital confirmed RASyn’s existence. Senior Managing Director Josh Resnick told STAT it’s part of the firm’s work to rethink how it develops platforms — core technologies or scientific approaches that underpin all of the drugs a biotech develops — but declined to comment further.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： STAT Boddities: What happens to the brain when we get scared?

hotspot

WSS

Readout Newsletter: Replicate, Biogen's Leqembi, and Humira

Resistance to opioid

Long Covid research funding gets a major boost from NIH

Long Covid research funding gets a major boost from NIH

Ebola vaccine can save some who are already sick, per new study

Here’s what’s in the FDA plan to include pregnant women in clinical trials

hotspot

explore

Wikipedia

Malaria cases in Florida and Texas: Here’s what you need to know

Too many hospitalized Covid

Psychedelics group wrestles with new pharma identity

Abbott's new heart device gets FDA advisory panel nod

Guidelines to prevent youth baseball injuries need more muscle

Abbott's new heart device gets FDA advisory panel nod

Wildfire smoke exposes gaps in outdoor worker protections

Doctors on social media are being harassed and cyberbullied

New air purifier tech could be key to improving indoor air quality

Juul documents reveal insider tactics on political lobbying

leisure time

STAT Boddities: What happens to the brain when we get scared?

Doctors on social media are being harassed and cyberbullied

Juul documents reveal insider tactics on political lobbying

Long Covid research funding gets a major boost from NIH

Report cites 'urgent' need to recruit more diverse clinical trial participants

Websites selling Wegovy, Zepbound ingredients targeted by FDA

hotspot

focus

leisure time

focus